Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Summary of opinion: Abiraterone Mylan, 17/09/2026 Positive
Benefits of sodium oxybate continue to outweigh risks in people with alcohol dependency
EMA concludes review of ipidacrine-containing medicines
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled, Status: Opinion
Summary of opinion: Tecvayli, 17/09/2026 Positive
Summary of opinion: Sogroya, 17/09/2026 Positive
Withdrawn application: Alhemo, 10/09/2026
Referral: Sodium oxybate-containing syrup and oral solution for alcohol dependence, sodium oxybate Article 31 referrals CHMP opinion, 17/09/2026, 18/09/2026
Referral: Ipidacrine-containing medicinal products, ipidacrine Article 31 referrals CHMP opinion, 17/09/2026, 18/09/2026
Summary of opinion: Keytruda, 17/09/2026 Positive